A means of normalizing renal function and method thereof

 

The invention relates to medicine, namely to the production of medicines from animal products. The pharmacological agent is a low molecular weight fraction of the extract on renal tissue of farm animals and as the active agent contains an amino acid complex in a concentration of from 3.0 to 4.0 mg/ml of amine nitrogen and peptides at a concentration of from 9.0 to 11.0 mg/ml, with maximum absorption in the ultraviolet spectrum at wavelength (2705) nm and characterized by the value of molecular weight is not more than 10-15 KD. To obtain the tissue of the kidneys slaughter of farm animals are crushed, extracted with acetic acid, the resulting substrate is frozen at a temperature of minus 5 to 20oWith subsequent thawing and dodging, secrete low molecular weight fraction by ultrafiltration on a membrane with a selectivity 10-15 KD, to the obtained filtrate add stabilizer, sterilized, dispensed into ampoules and lyophilizers. The resulting tool effectively normalizes the function of the kidneys, for which it is used in a dose of 0.1-0.25 mg/kg body weight for 10 days table. 3 S. p. f-crystals, 8 PL.

The text descriptions in facsimille to normalize kidney function, representing low molecular weight fraction of the extract on renal tissue of farm animals, characterized in that the active agent contains an amino acid complex in a concentration of from 3.0 to 4.0 mg/ml of amine nitrogen and peptides at a concentration of from 9.0 to 11.0 mg/ml, with maximum absorption in the ultraviolet spectrum at wavelength (2705) nm and characterized by the value of molecular weight is not more than 10-15 KD.

2. A method of obtaining a pharmacological tool for the normalization of kidney function, including tissue grinding kidney slaughter of farm animals, the extraction of acetic acid and isolation of low molecular weight fractions of the extract, characterized in that the obtained following extraction, the substrate is subjected to freezing at a temperature (-5)-(-20)With subsequent thawing and dodging, secrete low molecular weight fraction by ultrafiltration on a membrane with a selectivity 10-15 KD, to the obtained filtrate add stabilizer, sterilized, dispensed into ampoules and lyophilizers.

3. The method of normalization of functional activity of the kidneys through the application of pharmacological agents that represent low molecular weight fructicosa 0.1-0.25 mg/kg body weight for 10 days.

 

Same patents:

The invention relates to medicine, in particular to urology and Nephrology, and for the treatment of acute purulent pyelonephritis

The invention relates to medicine, in particular to oncourology

Pharmaceutical drug // 2213577
The invention relates to medicine

The invention relates to medicine and can be used to treat allergic reactions at a late stage and inflammatory diseases
The invention relates to medicine, in particular, urology

The invention relates to new compounds of the formula I or II or compounds selected from the following group, with activity against receptor calcium, pharmaceutical compositions and methods of treating diseases caused by abnormal mineral homeostasis, hyperparathyroidism, hypercalcemia, malignant tumors, osteoporosis, hypertension and renal osteodystrophies

The invention relates to medicine, namely to Nephrology, and can be used for the treatment of alcohol kidney damage

The invention relates to medicine, in particular to therapy, and relates to methods of treatment of patients with chronic glomerulonephritis

The invention relates to medicine and can be used for treatment of chronic pyelonephritis in the acute stage

The invention relates to medicine, in particular to ophthalmology, and can be used as ophthalmic medicines for the treatment of diseases and injuries of the cornea
The invention relates to medicine, in particular, neurology, and can be used for the treatment of immune disorders in patients with demyelinating diseases (multiple sclerosis, multiple encephalomyelitis)

The invention relates to peptides having the amino acid sequence of at least 5 amino acids are identical to part ner receptor, corresponding to amino acids 308-373 this receptor, excluding the peptide TEKKRRETVEREKE

The invention relates to medicine and biology, more specifically a process for the production of collagen, and can be used in the treatment of various tissue pathologies, for cell cultivation

The invention relates to medicine, in particular to immunology, and for inhibition of lymphocyte proliferation

The invention relates to the field of medicine and biotechnology and concerns peptide antagonists Sonoline

The invention relates to venereology and, in particular, to the treatment of syphilis in the absence of positive to negative reactions Wasserman

The invention relates to medicine and for the treatment and prevention of cholelithiasis
The invention relates to medicine, namely to urology and surgery, and can be used in organ-sparing operations on the kidney
Up!